Increased stability of the TM helix oligomer abrogates the apoptotic activity of the human Fas receptor.

Fiche publication

Date publication

octobre 2021

Journal

Biochimica et biophysica acta. Biomembranes

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BAGNARD Dominique

Tous les auteurs :
Steindorf D, Loeuillet A, Bagnard D, Strand S, Schneider D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34662567

Résumé

Human death receptors control apoptotic events during cell differentiation, cell homeostasis and the elimination of damaged or infected cells. Receptor activation involves ligand-induced structural reorganizations of preformed receptor trimers. Here we show that the death receptor transmembrane domains only have a weak intrinsic tendency to homo-oligomerize within a membrane, and thus these domains potentially do not significantly contribute to receptor trimerization. However, mutation of Pro183 in the human CD95/Fas receptor transmembrane helix results in a dramatically increased interaction propensity, as shown by genetic assays. The increased interaction of the transmembrane domain is coupled with a decreased ligand-sensitivity of cells expressing the Fas receptor, and thus in a decreased number of apoptotic events. Mutation of Pro183 likely results in a substantial rearrangement of the self-associated Fas receptor transmembrane trimer, which likely abolishes further signaling of the apoptotic signal but may activate other signaling pathways. Our study shows that formation of a stable Fas receptor transmembrane helix oligomer does not per se result in receptor activation.